These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26209866)
21. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140 [TBL] [Abstract][Full Text] [Related]
22. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Ardabili HR; Gargari BP; Farzadi L Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806 [TBL] [Abstract][Full Text] [Related]
23. Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study. Butler AE; Dargham SR; Abouseif A; El Shewehy A; Atkin SL J Steroid Biochem Mol Biol; 2021 Jul; 211():105892. PubMed ID: 33785436 [TBL] [Abstract][Full Text] [Related]
24. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086 [TBL] [Abstract][Full Text] [Related]
25. Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study. Haldar D; Agrawal N; Patel S; Kambale PR; Arora K; Sharma A; Tripathi M; Batra A; Kabi BC Eur J Nutr; 2018 Mar; 57(2):703-711. PubMed ID: 28008453 [TBL] [Abstract][Full Text] [Related]
26. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546 [TBL] [Abstract][Full Text] [Related]
27. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity. Tsakova AD; Gateva AT; Kamenov ZA Int J Vitam Nutr Res; 2012 Dec; 82(6):399-404. PubMed ID: 23823925 [TBL] [Abstract][Full Text] [Related]
28. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial. Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974 [TBL] [Abstract][Full Text] [Related]
29. Genotype-independent association between vitamin D deficiency and polycystic ovarian syndrome in Lahore, Pakistan. Lone NM; Riaz S; Eusaph AZ; Mein CA; Wozniak EL; Xenakis T; Wu Z; Younis S; Jolliffe DA; Junaid K; Martineau AR Sci Rep; 2020 Feb; 10(1):2290. PubMed ID: 32042037 [TBL] [Abstract][Full Text] [Related]
30. [The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders]. Brzozowska M; Karowicz-Bilińska A Ginekol Pol; 2013 Jun; 84(6):456-60. PubMed ID: 24032264 [TBL] [Abstract][Full Text] [Related]
31. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Mahmoudi T; Gourabi H; Ashrafi M; Yazdi RS; Ezabadi Z Fertil Steril; 2010 Mar; 93(4):1208-14. PubMed ID: 19230880 [TBL] [Abstract][Full Text] [Related]
32. Vitamin D and Lipid Profiles in Infertile PCOS and Non-PCOS Females. Azhar A; Alam SM; Rehman R J Coll Physicians Surg Pak; 2024 Jul; 34(7):767-770. PubMed ID: 38978237 [TBL] [Abstract][Full Text] [Related]
33. The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency. Atasayan K; Yoldemir T Gynecol Endocrinol; 2021 Mar; 37(3):225-229. PubMed ID: 32996333 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis. Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765 [TBL] [Abstract][Full Text] [Related]
35. A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. Nestler JE; Reilly ER; Cheang KI; Bachmann LM; Downs RW Trans Am Clin Climatol Assoc; 2012; 123():209-19; discussion 219-20. PubMed ID: 23303986 [TBL] [Abstract][Full Text] [Related]
36. Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study. Shan C; Zhu YC; Yu J; Zhang Y; Wang YY; Lu N; Cai J; Liu W; Tao T Front Endocrinol (Lausanne); 2022; 13():894935. PubMed ID: 35586624 [TBL] [Abstract][Full Text] [Related]
37. The relationship between Vitamin D deficiency and polycystic ovary syndrome. Gokosmanoglu F; Onmez A; Ergenç H Afr Health Sci; 2020 Dec; 20(4):1880-1886. PubMed ID: 34394253 [TBL] [Abstract][Full Text] [Related]
38. Vitamin D Status in Polycystic Ovarian Syndrome Patients Attending a Tertiary Hospital of Bangladesh. Kamrul-Hasan AB; Aalpona FZ; Chanda PK; Ariful-Islam M; Palash-Molla M; Rabaya-Akter M; Talukder RK; Siddiqui NI Mymensingh Med J; 2018 Oct; 27(4):730-736. PubMed ID: 30487487 [TBL] [Abstract][Full Text] [Related]
39. Association between serum 25(OH) vitamin D and metabolic disturbances in polycystic ovary syndrome. Keshavarz MA; Moradi S; Emami Z; Rohani F Neth J Med; 2017 Jun; 75(5):190-195. PubMed ID: 28653944 [TBL] [Abstract][Full Text] [Related]
40. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]